Skip to main content
James Marks, MD, Anesthesiology, San Francisco, CA

JamesDavidMarksMD

Anesthesiology San Francisco, CA

Critical Care Medicine

Professor, Anesthesia & Perioperative Care, UCSF School of Medicine

Dr. Marks is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Marks' full profile

Already have an account?

  • Office

    1001 Potrero Ave
    Rm 3c34
    San Francisco, CA 94110
    Phone+1 415-206-8934
    Fax+1 415-206-3101

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Anesthesiology, 1984 - 1986
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Critical Care Medicine (Anesthesiology), 1982 - 1983
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1979 - 1982
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1980 - 2026
  • American Board of Anesthesiology Anesthesiology
  • American Board of Anesthesiology Critical Care Medicine
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2006

Publications & Presentations

PubMed

Grant Support

  • Evolving Diagnostic Antibodies For Botulinum NeurotoxinsNational Institute Of Allergy And Infectious Diseases2011–2012
  • Development Of Botulinum Neurotoxin Immunotherapy, Serotypes C, D, F, And GNational Institute Of Allergy And Infectious Diseases2007–2011
  • Using Mass Spec To Determine Molecular Identity Of Tumor Specific AntigenNational Center For Research Resources2004–2011
  • Design And Generation Of Cross- Reactive Botulinum Neurotoxin AntibodiesNational Institute Of Allergy And Infectious Diseases2009–2010
  • Development Of Botulinum Neurotoxin ImmunotherapyNational Institute Of Allergy And Infectious Diseases2003–2007
  • Deciphering Toxin Neutralization By Oligoclonal AntibodyNational Institute Of Allergy And Infectious Diseases2002–2003
  • Phage Antibody Based Probes Of ERBB Receptor FunctionNational Cancer Institute2001–2002